Supplement made from Tomatoes may protect against heart disease
Scientists have found that a supplement made from tomatoes may protect against heart disease and strokes when taken daily. The supplement--called Ateronon--contains an active ingredient from the Mediterranean diet, lycopene, which blocks the bad cholesterol that can clog the arteries. In a preliminary trial of 150 patients with heart disease, Ateronon reduced the oxidation of harmful fats in the blood to almost zero within eight weeks. Though the supplement is being launched as a dietary supplement, experts say more trials are needed to determine its effectiveness.
Heart drug combinations linked to GI bleeding
According to new research, common drug combinations used to treat heart disease may increase a patient's risk of developing upper gastrointestinal (GI) tract perforations or bleeding. For the study, investigators looked at data on 78,084 patients from a Department of Veterans Affairs database. About 30 percent were prescribed combinations of two or three drugs to treat heart disease such as anticoagulant-antiplatelet (ACAP), aspirin-antiplatelet (ASAP), aspirin-anticoagulant (ASAC), or TRIP (aspirin-anticoagulant-antiplatelet). The researchers found that patients prescribed TRIP were four times more likely to have an upper GI bleed, while those given ASAP and ASAC drug combinations were two and a half times more likely. The fewest upper GI problems occurred among people taking ACAP.
Scientists have found that a supplement made from tomatoes may protect against heart disease and strokes when taken daily. The supplement--called Ateronon--contains an active ingredient from the Mediterranean diet, lycopene, which blocks the bad cholesterol that can clog the arteries. In a preliminary trial of 150 patients with heart disease, Ateronon reduced the oxidation of harmful fats in the blood to almost zero within eight weeks. Though the supplement is being launched as a dietary supplement, experts say more trials are needed to determine its effectiveness.
Heart drug combinations linked to GI bleeding
According to new research, common drug combinations used to treat heart disease may increase a patient's risk of developing upper gastrointestinal (GI) tract perforations or bleeding. For the study, investigators looked at data on 78,084 patients from a Department of Veterans Affairs database. About 30 percent were prescribed combinations of two or three drugs to treat heart disease such as anticoagulant-antiplatelet (ACAP), aspirin-antiplatelet (ASAP), aspirin-anticoagulant (ASAC), or TRIP (aspirin-anticoagulant-antiplatelet). The researchers found that patients prescribed TRIP were four times more likely to have an upper GI bleed, while those given ASAP and ASAC drug combinations were two and a half times more likely. The fewest upper GI problems occurred among people taking ACAP.
No comments:
Post a Comment